US Stock MarketDetailed Quotes

SYRS Syros Pharmaceuticals

Watchlist

6.0000
+0.2000+3.45%

Close Jun 14 16:00 ET

5.8000
-0.2000-3.33%

Post 16:35 ET

160.37MMarket Cap-1185P/E (TTM)

Syros Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

-33.23%9.94M

151.19%386K

-3.32%3.76M

-54.86%2.83M

-45.97%2.95M

-36.65%14.88M

-109.66%-754K

-31.70%3.89M

21.58%6.28M

Operating revenue

--0

-33.23%9.94M

151.19%386K

-3.32%3.76M

-54.86%2.83M

-45.97%2.95M

-36.65%14.88M

-109.66%-754K

-31.70%3.89M

21.58%6.28M

Cost of revenue

Gross profit

Operating expense

-14.50%30.92M

-3.40%136.44M

-22.28%27.39M

6.53%36.04M

-8.02%36.83M

12.60%36.17M

14.92%141.24M

6.07%35.24M

3.76%33.84M

27.91%40.05M

Selling and administrative expenses

-15.38%6.27M

-3.47%28.28M

-19.66%5.89M

-3.86%7.76M

4.03%7.23M

6.56%7.41M

27.19%29.3M

13.98%7.33M

51.07%8.08M

25.82%6.95M

-General and administrative expense

-15.38%6.27M

-3.47%28.28M

-19.66%5.89M

-3.86%7.76M

4.03%7.23M

6.56%7.41M

27.19%29.3M

13.98%7.33M

51.07%8.08M

25.82%6.95M

Research and development costs

-14.28%24.66M

-3.39%108.15M

-22.97%21.5M

9.79%28.28M

-10.55%29.61M

14.26%28.76M

12.09%111.94M

4.18%27.91M

-5.51%25.76M

28.36%33.1M

Operating profit

6.90%-30.92M

-0.11%-126.5M

24.98%-27.01M

-7.81%-32.28M

-0.68%-34M

-24.61%-33.21M

-27.10%-126.36M

-41.59%-36M

-11.27%-29.94M

-29.17%-33.77M

Net non-operating interest income expense

-57.17%239K

184.37%1.69M

-109.85%-46K

150.08%330K

197.47%847K

159.30%558K

47.59%-2M

148.90%467K

30.78%-659K

9.20%-869K

Non-operating interest income

-12.90%1.55M

219.70%6.82M

-19.46%1.28M

316.58%1.63M

1,797.32%2.13M

4,971.43%1.78M

2,350.57%2.13M

5,038.71%1.59M

1,125.00%392K

833.33%112K

Non-operating interest expense

7.40%1.31M

24.02%5.13M

18.03%1.33M

23.98%1.3M

30.28%1.28M

24.69%1.22M

5.81%4.13M

14.20%1.13M

6.81%1.05M

1.24%981K

Other net income (expense)

204.28%26.97M

-217.96%-39.76M

-221.38%-37.33M

-2,440.29%-8.19M

-2,077.71%-3.11M

262.13%8.87M

102.08%33.71M

1,099.06%30.76M

-80.94%350K

-96.60%157K

Gain on sale of security

204.28%26.97M

-186.24%-37.28M

-220.95%-37.2M

-159.20%-5.84M

-2,077.71%-3.11M

262.13%8.87M

159.09%43.22M

1,099.06%30.76M

437.04%9.86M

-96.60%157K

Special income (charges)

----

73.83%-2.49M

---135K

75.25%-2.35M

----

---9.51M

--0

---9.51M

----

-Less：Restructuring and merger&acquisition

----

-73.83%2.49M

--135K

-75.25%2.35M

----

--9.51M

--0

--9.51M

----

Income before tax

84.41%-3.71M

-73.87%-164.57M

-1,248.64%-64.38M

-32.69%-40.14M

-5.15%-36.26M

5.40%-23.79M

-9.35%-94.65M

79.95%-4.77M

-16.24%-30.25M

-53.32%-34.48M

Income tax

Net income

84.41%-3.71M

-73.87%-164.57M

-1,248.64%-64.38M

-32.69%-40.14M

-5.15%-36.26M

5.40%-23.79M

-9.35%-94.65M

79.95%-4.77M

-16.24%-30.25M

-53.32%-34.48M

Net income continuous Operations

84.41%-3.71M

-73.87%-164.57M

-1,248.64%-64.38M

-32.69%-40.14M

-5.15%-36.26M

5.40%-23.79M

-9.35%-94.65M

79.95%-4.77M

-16.24%-30.25M

-53.32%-34.48M

Minority interest income

Net income attributable to the parent company

84.41%-3.71M

-73.87%-164.57M

-1,248.64%-64.38M

-32.69%-40.14M

-5.15%-36.26M

5.40%-23.79M

-9.35%-94.65M

79.95%-4.77M

-16.24%-30.25M

-53.32%-34.48M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

84.41%-3.71M

-73.87%-164.57M

-1,248.64%-64.38M

-32.69%-40.14M

-5.15%-36.26M

5.40%-23.79M

-9.35%-94.65M

79.95%-4.77M

-16.24%-30.25M

-53.32%-34.48M

Basic earnings per share

88.24%-0.1

22.43%-5.81

-842.28%-2.22

55.45%-1.43

75.93%-1.3

78.70%-0.85

45.88%-7.49

93.77%-0.2356

22.46%-3.21

-50.00%-5.4

Diluted earnings per share

88.24%-0.1

22.43%-5.81

-842.28%-2.22

55.45%-1.43

75.93%-1.3

78.70%-0.85

45.88%-7.49

93.77%-0.2356

22.46%-3.21

-50.00%-5.4

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	-33.23%9.94M	151.19%386K	-3.32%3.76M	-54.86%2.83M	-45.97%2.95M	-36.65%14.88M	-109.66%-754K	-31.70%3.89M	21.58%6.28M
Operating revenue	--0	-33.23%9.94M	151.19%386K	-3.32%3.76M	-54.86%2.83M	-45.97%2.95M	-36.65%14.88M	-109.66%-754K	-31.70%3.89M	21.58%6.28M
Cost of revenue
Gross profit
Operating expense	-14.50%30.92M	-3.40%136.44M	-22.28%27.39M	6.53%36.04M	-8.02%36.83M	12.60%36.17M	14.92%141.24M	6.07%35.24M	3.76%33.84M	27.91%40.05M
Selling and administrative expenses	-15.38%6.27M	-3.47%28.28M	-19.66%5.89M	-3.86%7.76M	4.03%7.23M	6.56%7.41M	27.19%29.3M	13.98%7.33M	51.07%8.08M	25.82%6.95M
-General and administrative expense	-15.38%6.27M	-3.47%28.28M	-19.66%5.89M	-3.86%7.76M	4.03%7.23M	6.56%7.41M	27.19%29.3M	13.98%7.33M	51.07%8.08M	25.82%6.95M
Research and development costs	-14.28%24.66M	-3.39%108.15M	-22.97%21.5M	9.79%28.28M	-10.55%29.61M	14.26%28.76M	12.09%111.94M	4.18%27.91M	-5.51%25.76M	28.36%33.1M
Operating profit	6.90%-30.92M	-0.11%-126.5M	24.98%-27.01M	-7.81%-32.28M	-0.68%-34M	-24.61%-33.21M	-27.10%-126.36M	-41.59%-36M	-11.27%-29.94M	-29.17%-33.77M
Net non-operating interest income expense	-57.17%239K	184.37%1.69M	-109.85%-46K	150.08%330K	197.47%847K	159.30%558K	47.59%-2M	148.90%467K	30.78%-659K	9.20%-869K
Non-operating interest income	-12.90%1.55M	219.70%6.82M	-19.46%1.28M	316.58%1.63M	1,797.32%2.13M	4,971.43%1.78M	2,350.57%2.13M	5,038.71%1.59M	1,125.00%392K	833.33%112K
Non-operating interest expense	7.40%1.31M	24.02%5.13M	18.03%1.33M	23.98%1.3M	30.28%1.28M	24.69%1.22M	5.81%4.13M	14.20%1.13M	6.81%1.05M	1.24%981K
Other net income (expense)	204.28%26.97M	-217.96%-39.76M	-221.38%-37.33M	-2,440.29%-8.19M	-2,077.71%-3.11M	262.13%8.87M	102.08%33.71M	1,099.06%30.76M	-80.94%350K	-96.60%157K
Gain on sale of security	204.28%26.97M	-186.24%-37.28M	-220.95%-37.2M	-159.20%-5.84M	-2,077.71%-3.11M	262.13%8.87M	159.09%43.22M	1,099.06%30.76M	437.04%9.86M	-96.60%157K
Special income (charges)	----	73.83%-2.49M	---135K	75.25%-2.35M	----	----	---9.51M	--0	---9.51M	----
-Less：Restructuring and merger&acquisition	----	-73.83%2.49M	--135K	-75.25%2.35M	----	----	--9.51M	--0	--9.51M	----
Income before tax	84.41%-3.71M	-73.87%-164.57M	-1,248.64%-64.38M	-32.69%-40.14M	-5.15%-36.26M	5.40%-23.79M	-9.35%-94.65M	79.95%-4.77M	-16.24%-30.25M	-53.32%-34.48M
Income tax
Net income	84.41%-3.71M	-73.87%-164.57M	-1,248.64%-64.38M	-32.69%-40.14M	-5.15%-36.26M	5.40%-23.79M	-9.35%-94.65M	79.95%-4.77M	-16.24%-30.25M	-53.32%-34.48M
Net income continuous Operations	84.41%-3.71M	-73.87%-164.57M	-1,248.64%-64.38M	-32.69%-40.14M	-5.15%-36.26M	5.40%-23.79M	-9.35%-94.65M	79.95%-4.77M	-16.24%-30.25M	-53.32%-34.48M
Minority interest income
Net income attributable to the parent company	84.41%-3.71M	-73.87%-164.57M	-1,248.64%-64.38M	-32.69%-40.14M	-5.15%-36.26M	5.40%-23.79M	-9.35%-94.65M	79.95%-4.77M	-16.24%-30.25M	-53.32%-34.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	84.41%-3.71M	-73.87%-164.57M	-1,248.64%-64.38M	-32.69%-40.14M	-5.15%-36.26M	5.40%-23.79M	-9.35%-94.65M	79.95%-4.77M	-16.24%-30.25M	-53.32%-34.48M
Basic earnings per share	88.24%-0.1	22.43%-5.81	-842.28%-2.22	55.45%-1.43	75.93%-1.3	78.70%-0.85	45.88%-7.49	93.77%-0.2356	22.46%-3.21	-50.00%-5.4
Diluted earnings per share	88.24%-0.1	22.43%-5.81	-842.28%-2.22	55.45%-1.43	75.93%-1.3	78.70%-0.85	45.88%-7.49	93.77%-0.2356	22.46%-3.21	-50.00%-5.4
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall